Spain News Network
SEE OTHER BRANDS

Following the news from Spain

Spain News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Spain News Network.

Press releases published on August 25, 2025

Sovereign streaming for Europe’s digital decade: G&L Systemhaus defines resilient infrastructures

Sovereign streaming for Europe’s digital decade: G&L Systemhaus defines resilient infrastructures

Institutions and broadcasters gain trusted streaming workflows designed for reliable control, sustainable growth, and future-proof performance. COLOGNE, GERMANY, August 25, 2025 /⁨EINPresswire.com⁩/ -- G…

Labelexpo 2025 to Unveil the Future of Rotogravure Printing, Supported by Expanding Packaging and Publishing Sectors

Labelexpo 2025 to Unveil the Future of Rotogravure Printing, Supported by Expanding Packaging and Publishing Sectors

Rising demand for high-speed, high-quality, and cost-efficient printing solutions drives growth in rotogravure printing machines market. NEWARK, DE, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- The global printing and packaging industry is abuzz …

XS.com Gana el Premio a la “Mejor Investigación de Mercado” en Money Expo India 2025

XS.com Gana el Premio a la “Mejor Investigación de Mercado” en Money Expo India 2025

COLOMBIA, August 25, 2025 /⁨Business News⁩/ -- XS.com, la principal firma global de FinTech y corretaje multi-activos, fue galardonada con el premio a la “Mejor Investigación de Mercado” en Money Expo India 2025, celebrado los días 23 y 24 de agosto en el …

ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease

ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease

First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions